← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2015Last known activity
Apr 25, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06223854OfficialN/AApr 25, 2024
- NCT06223854CollaboratorN/AApr 25, 2024
- NCT06056089CollaboratorN/ASep 25, 2023
- NCT06061484Overall official - principal investigatorN/ASep 25, 2023
- NCT06056089Overall official - principal investigatorN/ASep 25, 2023
- NCT06061484CollaboratorN/ASep 25, 2023
- NCT06044805OfficialPhase 4Dec 19, 2022
- NCT06044805CollaboratorPhase 4Dec 19, 2022
- NCT06044805Study directorPhase 4Dec 19, 2022
- NCT04411836CollaboratorPhase 3Jan 1, 2021
- NCT02363985Reponsible party - principal investigatorN/ANov 1, 2015
- NCT02363985Lead sponsorN/ANov 1, 2015
Details
- Last known activity
- Apr 25, 2024